Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
OTC Hearing Aids Just as Effective as Prescription Devices for Most: Study The findings come after the FDA approved the sale of hearing aids over-the-counter late last year. June 13, 2023 Martha Garcia Add Your Comments With a growing number of over-the-counter hearing aids being marketed directly to consumers, after the FDA approved the direct sale of products for individuals to mild to moderate hearing loss last year, the findings of a new study suggest the OTC devices appear to be just as effective as prescription hearing aids specially fitted by doctors. The FDA established a new category for OTC hearing aids in October 2022, to improve access to the expensive devices and foster innovations in hearing aid technology that could widely help a large number of adult throughout the U.S. In findings of a study recently published in the medical journal JAMA Otolaryngology-Head & Neck Surgery, researchers from the University of Colorado and the University of Pretoria in South Africa indicate that there is little difference in the effectiveness of TOC hearing aids that are self-fitted, compared to prescription hearing aids, after six weeks of testing. Researchers conducted a randomized clinical trial involving 64 adults with hearing loss from April 14 to August 29, 2022. They compared patients who had self-perceived mild to moderate hearing loss, and assigned participants to either receive hearing aids fitted by an audiologist or provided self-fit OTC hearing aids with instructional material and an accompanying smartphone app to help with fit and use. Participants completed a two-week take-home trial without any support. Then after the trial, they were given access to fine-tuning. Support and adjustment were provided remotely for the self-fitting group and by the audiologist for the audiologist-fitted group. Participants were then reassessed after an additional four-week take-home trial. The findings indicate hearing and recognizing speech was the same in the OTC hearing aid group as it was for the audiologist-fitted hearing aid group. After the two-week mark, hearing tests indicated the self-fitted OTC hearing aid group fared better on some tests but not on others compared to the audiologist group. Individuals using OTC hearing aids scored better on the Abbreviated Profile of Hearing Aid Benefit test, a measure of speech communication and hearing in noisy environments, as well as the International Outcome Inventory for Hearing Aids test, which evaluates the effectiveness of hearing aids, than patients who used audiologist fitted hearing aids. However, the OTC hearing aid group scored worse on speech recognition in noise compared to the doctor-prescribed group. By the six-week mark, outcomes for both groups were the same, the researchers found. There were no meaningful differences in hearing measures or scoring on hearing tests. FDA Approves OTC Hearing Aids Roughly 30 million adults in the country suffer from hearing loss, but less than 20% of adults with hearing loss use hearing aids. However, previous research indicates hearing aids may help patients suffering from dementia improve or alleviate cognitive decline or depression. Tepezza Lawsuits Did You or a Loved One Receive a Tepezza Injection? Side effects of Tepezza may cause permanent hearing problems. Lawsuits are being pursued over the drug maker’s failure to warn about the risk. Find out if qualify for a settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Tepezza Lawsuits Did You or a Loved One Receive a Tepezza Injection? Side effects of Tepezza may cause permanent hearing problems. Lawsuits are being pursued over the drug maker’s failure to warn about the risk. Find out if qualify for a settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The FDA approved a new category of OTC hearing aids, which is largely seen as a move to reduce hearing aid costs, which traditionally cost roughly $2,800 or more per pair. Clinical studies of currently available OTC hearing aids are limited. This study only compared one brand of OTC hearing aids to doctor-prescribed hearing aids, even though there are other brands available on the market. Yet, the findings of this study indicate OTC hearing aids may be as effective an option for people with mild to moderate hearing loss, the researchers concluded. They indicated OTC hearing aids can lead to both clinical and self-perceived outcomes similar to those a patient can experience with audiologist-fitted hearing aids. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Hearing Aid, Hearing Loss More Tepezza Lawsuit Stories Tepezza Bellwether Deadlines Stricken, Raising Speculation of Hearing Loss Settlement October 14, 2025 Tepezza Hearing Loss Trial Date Pushed Back to Aug. 2026 August 27, 2025 Tepezza Lawsuit Claims Thyroid Eye Disease Drug Caused Hearing Loss, Tinnitus August 13, 2025 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 4 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025) Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 5 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025) Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 6 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)
Tepezza Bellwether Deadlines Stricken, Raising Speculation of Hearing Loss Settlement October 14, 2025
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 4 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 5 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)
Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 6 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)